Medicines by class

Antineoplastic & immunomodulating

Cancer therapies and immune-modulating medicines.

411 medications in this class

Adalimumab

Tumor necrosis factor alpha (TNF-alpha) inhibitors

AbriladaAmjevitaCyltezoHadlima

Ustekinumab

Interleukin inhibitors

ImuldosaOtulfiPyzchivaSelarsdi

Ethinyl Estradiol

AnnoveraEluRyngEnilloringFemhrt

Methotrexate

Folic acid analogues

JylamvoOtrexupRasuvoReditrex

Leuprolide

Gonadotropin releasing hormone analogues

CamceviEligardFensolviLupron

Tretinoin

Retinoids for cancer treatment

AltrenoAtralinAvitaRefissa

Cyclosporine

Calcineurin inhibitors

AtopicaCequaCyclavanceGengraf

Filgrastim

Colony stimulating factors

GranixNeupogenNivestymNypozi

Trastuzumab

HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors

EnhertuHerceptinHerceptin HylectaHercessi

Tocilizumab

Interleukin inhibitors

ActemraAvtozmaTofidenceTyenne

Gemcitabine

Pyrimidine analogues

AvgemsiInfugemInlexzo

Tacrolimus

Calcineurin inhibitors

AstagrafEnvarsusPrograf

Bevacizumab

VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors

AlymsysAvastinAvziviJobevne

Medroxyprogesterone

Depo-ProveraProveradepo-subQ provera

Everolimus

Mammalian target of rapamycin (mTOR) kinase inhibitors

AfinitorTorpenzZortress

Pegfilgrastim

Colony stimulating factors

ArmlupegFulphilaFylnetraNeulasta

Aflibercept

Other antineoplastic agents

AhzantiveEydenzeltEyleaOpuviz

Ruxolitinib

Janus-associated kinase (JAK) inhibitors

Pemetrexed

Folic acid analogues

AlimtaAxtlePemfexyPemrydi Rtu

Ponesimod

Sphingosine-1-phosphate (S1P) receptor modulators

Rituximab

CD20 (Clusters of Differentiation 20) inhibitors

RiabniRituxanRituxan HycelaRuxience

Dasatinib

BCR-ABL tyrosine kinase inhibitors

Fluorouracil

Pyrimidine analogues

AdrucilCaracEfudexFavlyxa

Sirolimus

Mammalian target of rapamycin (mTOR) kinase inhibitors

FelycinFyarroHyftorRapamune

Interferon Beta-1a

Cyclophosphamide

Nitrogen mustard analogues

Etanercept

Tumor necrosis factor alpha (TNF-alpha) inhibitors

Emapalumab

Monoclonal antibodies

Hydroxyurea

Other antineoplastic agents

DroxiaHydreaSiklosXromi

Nivolumab

PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors

OpdivoOpdivo QvantigOpdualag

Risankizumab

Interleukin inhibitors

Temozolomide

Other alkylating agents

Docetaxel

Doxorubicin

Anthracyclines and related substances

AdriamycinCaelyxDoxil

Ibrutinib

Bruton's tyrosine kinase (BTK) inhibitors

Nilotinib

BCR-ABL tyrosine kinase inhibitors

DanzitenTasigna

Alpelisib

Phosphatidylinositol-3-kinase (Pi3K) inhibitors

Histamine

Other immunostimulants

ActivOn ArthritisAlo

Infliximab

Tumor necrosis factor alpha (TNF-alpha) inhibitors

AvsolaInflectraRemicadeRenflexis

Lenalidomide

Other immunosuppressants

Mitomycin

Other cytotoxic antibiotics

JelmytoMitosolMutamycinZusduri

Niraparib

Poly (ADP-ribose) polymerase (PARP) inhibitors

Palbociclib

Cyclin-dependent kinase (CDK) inhibitors

Peginterferon Beta-1a

Selinexor

Other antineoplastic agents

Selpercatinib

Other protein kinase inhibitors

Talazoparib

Poly (ADP-ribose) polymerase (PARP) inhibitors

Thiotepa

Ethylene imines

TepadinaTepylute

See all 411 in Antineoplastic & immunomodulating →

Other therapeutic classes